Target Price | $13.77 |
Price | $6.00 |
Potential |
129.50%
register free of charge
|
Number of Estimates | 6 |
6 Analysts have issued a price target Generation Bio Co 2026 .
The average Generation Bio Co target price is $13.77.
This is
129.50%
register free of charge
$73.50
1,125.00%
register free of charge
$10.10
68.33%
register free of charge
|
|
A rating was issued by 12 analysts: 9 Analysts recommend Generation Bio Co to buy, 3 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Generation Bio Co stock has an average upside potential 2026 of
129.50%
register free of charge
|
Dec '24 |
2025 Estimates |
|
---|---|---|
Revenue Million $ | 19.89 | 12.36 |
237.12% | 37.86% | |
EBITDA Margin | -373.35% | -693.26% |
83.47% | 85.68% | |
Net Margin | -661.99% | -639.51% |
69.15% | 3.40% |
8 Analysts have issued a sales forecast Generation Bio Co 2025 . The average Generation Bio Co sales estimate is
This results in the following potential growth metrics:
3 Analysts have issued an Generation Bio Co EBITDA forecast 2025. The average Generation Bio Co EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
8 Generation Bio Co Analysts have issued a net profit forecast 2025. The average Generation Bio Co net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Dec '24 |
2025 Estimates |
|
---|---|---|
Earnings Per Share $ | -19.76 | -11.74 |
0.66% | 40.59% | |
P/E | negative | |
EV/Sales | negative |
8 Analysts have issued a Generation Bio Co forecast for earnings per share. The average Generation Bio Co EPS is
This results in the following potential growth metrics and future valuations:
Generation Bio Co...
Analyst | Rating | Action | Date |
---|---|---|---|
Canaccord Genuity |
Locked
➜
Locked
|
Locked | Aug 18 2025 |
Needham |
Locked
➜
Locked
|
Locked | Aug 13 2025 |
Wedbush |
Locked
➜
Locked
|
Locked | Aug 13 2025 |
Needham |
Locked
➜
Locked
|
Locked | May 08 2025 |
Needham |
Locked
➜
Locked
|
Locked | Apr 10 2025 |
Canaccord Genuity |
Locked
➜
Locked
|
Locked | Mar 17 2025 |
Citizens Capital Markets |
Locked
➜
Locked
|
Locked | Mar 14 2025 |
Analyst Rating | Date |
---|---|
Locked
Canaccord Genuity:
Locked
➜
Locked
|
Aug 18 2025 |
Locked
Needham:
Locked
➜
Locked
|
Aug 13 2025 |
Locked
Wedbush:
Locked
➜
Locked
|
Aug 13 2025 |
Locked
Needham:
Locked
➜
Locked
|
May 08 2025 |
Locked
Needham:
Locked
➜
Locked
|
Apr 10 2025 |
Locked
Canaccord Genuity:
Locked
➜
Locked
|
Mar 17 2025 |
Locked
Citizens Capital Markets:
Locked
➜
Locked
|
Mar 14 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.